Skip to main content

California's Virtual Talc Trial Against J&J Ends In Mistrial

California's Virtual Talc Trial Against J&J Ends In Mistrial

California's Virtual Talc Trial Against J&J Ends In Mistrial

Introduction

California state court's virtual cosmetic talcum powder trial against Johnson & Johnson (J&J) ended in a mistrial after the plaintiff's health worsened, making him unable to communicate with his attorneys and resulting in his death.

The trial involved a 54-year-old man who had alleged that he developed mesothelioma after being exposed to asbestos and talc present in J&J's Baby Powder. Last week, Alameda County Superior Court Judge Stephen Kaus indicated that the plaintiff entered hospice due to his rapidly deteriorating health condition and was not expected to recover. Hon. Kaus informed jurors, via Zoom, that he would have to declare a mistrial.

The death of the plaintiff would likely change the nature of the case to involve wrongful death claims. The trial was being closely monitored as it was the first virtual talcum powder cancer trial since the COVID-19 pandemic outbreak.

Last month, the pharmaceutical giant agreed to pay over $100 million to resolve about 1,000 lawsuits over its talcum powder products brought by at least three law firms, which include Simmons Hanly Conroy, Simon Greenstone Panatier PC, and the Lanier Law Firm.

Currently, J&J is facing more than 20,000 Baby Powder and Shower-to-Shower lawsuits. Most of the lawsuits are consolidated under MDL No.: 2738, whereas some are pending in state courts in Pennsylvania. Lawsuits are also pending in a California coordinated proceeding as a part of Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Opioid addiction market to reach $2.4B by 2033

Categories: Opioids

The opioid addiction market across eight major markets (8MM) is projected to grow at a compound annual growth rate (CAGR) of 1.8% from $…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!